BioHealth News Archive

TEDCO’s Maryland Innovation Initiative Infuses $2.63M in New Round of Projects

TEDCO’s Maryland Innovation Initiative Infuses $2.63M in New Round of Projects

COLUMBIA, Md., Jan. 8, 2020 /PRNewswire/ -- TEDCO, Maryland's economic engine for technology companies, announced its recent round of funding for select projects through the…

Read More
CIT GAP Funds Invests in Jeeva to Decentralize and Improve Clinical Trial Operations

CIT GAP Funds Invests in Jeeva to Decentralize and Improve Clinical Trial Operations

The Center for Innovative Technology (CIT) today announced that CIT GAP Funds has invested in Herndon, Va.-based Jeeva Informatics Solutions Inc. (Jeeva), a precision…

Read More
NexImmune Appoints Industry Veteran Chief Medical Officer to Executive Team · BioBuzz

NexImmune Appoints Industry Veteran Chief Medical Officer to Executive Team · BioBuzz

NexImmune, a clinical-stage biopharmaceutical company developing novel immune-therapeutics based on a proprietary Artificial Immune Modulation (AIM) nanotechnology platform, announced that industry veterans Han Myint,…

Read More
NexImmune Bolsters Leadership Team Adding Former MedImmune Executive as Chief Financial Officer · BioBuzz

NexImmune Bolsters Leadership Team Adding Former MedImmune Executive as Chief Financial Officer · BioBuzz

NexImmune, a clinical-stage biopharmaceutical company developing novel immune-therapeutics based on a proprietary Artificial Immune Modulation (AIM) nanotechnology platform, announced that industry veteran John Trainer,…

Read More
LumaCyte Awarded Frost & Sullivan 2019 Global Single-Cell Analysis New Product Innovation Award for Its Novel Laser Force Cytology™ Technology

LumaCyte Awarded Frost & Sullivan 2019 Global Single-Cell Analysis New Product Innovation Award for Its Novel Laser Force Cytology™ Technology

SANTA CLARA, Calif., Jan. 7, 2020 /PRNewswire/ -- Based on its recent analysis of the global single-cell analysis market, Frost & Sullivan recognizes LumaCyte, LLC…

Read More
NexImmune Expands Executive Team with Appointments of Chief Medical Officer and Chief Financial Officer

NexImmune Expands Executive Team with Appointments of Chief Medical Officer and Chief Financial Officer

GAITHERSBURG, Md., Jan. 09, 2020 (GLOBE NEWSWIRE) -- NexImmune, a clinical-stage biopharmaceutical company developing novel immune-therapeutics based on a proprietary Artificial Immune Modulation (AIM)…

Read More
Laboratory Space Available

Laboratory Space Available

Alexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500® REIT, is the first and longest-tenured owner, operator, and developer uniquely focused on collaborative life…

Read More
UMB, JHU Collaborate to Advance Drug Discovery – University of Maryland, Baltimore

UMB, JHU Collaborate to Advance Drug Discovery – University of Maryland, Baltimore

The University of Maryland School of Pharmacy welcomed nearly 200 researchers from across the University of Maryland, Baltimore (UMB) and Johns Hopkins University (JHU)…

Read More
GlycoMimetics and Apollomics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Uproleselan and GMI-1687 in Greater China – GlycoMimetics, Inc.

GlycoMimetics and Apollomics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Uproleselan and GMI-1687 in Greater China – GlycoMimetics, Inc.

ROCKVILLE, Md. & FOSTER CITY, Calif. & HANGZHOU, China--(BUSINESS WIRE)--Jan. 6, 2020-- GlycoMimetics, Inc. (NASDAQ: GLYC), a leader in the field of applied glycotechnology…

Read More
Biotech, life sciences incubator opens in Manhattan | Real Estate Weekly

Biotech, life sciences incubator opens in Manhattan | Real Estate Weekly

The largest biotechnology incubator of its kind in New York City has opened at 180 Varick Street in Hudson Square. BioLabs @ NYULangone is…

Read More
(New Year Special) Investors vulnerable to risky biotech business – Korea Biomedical Review

(New Year Special) Investors vulnerable to risky biotech business – Korea Biomedical Review

President Moon Jae-in announced in May that the government would designate the biohealth industry as one of the three new sectors for future growth,…

Read More
New Theory For Cancer Immunotherapy – University of Maryland, Baltimore

New Theory For Cancer Immunotherapy – University of Maryland, Baltimore

Scientists from the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) this week proposed a new theory, based on…

Read More
TEDCO, NIST give four companies funding – Maryland Daily Record

TEDCO, NIST give four companies funding – Maryland Daily Record

The Maryland Technology Development Corp. and the National Institute of Standards and Technology awarded four companies a total of $448,000 to develop NIST-licensed technologies…

Read More
TEDCO is ready to invest again, Maryland Venture Fund remains on hold – Baltimore Business Journal

TEDCO is ready to invest again, Maryland Venture Fund remains on hold – Baltimore Business Journal

Eight months after Maryland Technology Development Corp. halted investments through some of its funds, the state-backed organization announced Friday it is ready to accept…

Read More
Research Hailed for Making the World a Better Place – University of Maryland, Baltimore

Research Hailed for Making the World a Better Place – University of Maryland, Baltimore

The University of Maryland School of Medicine is being recognized by a national news publication for groundbreaking biomedical research that “is making the world…

Read More